Clinical Trial Update: Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating blinatumomab in adults with high-risk B-cell precursor acute lymphoblastic leukemia is ongoing (active, not recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Lymphoblastic Leukemia, Adult B-Cell | Phase 2 | Status: ACTIVE_NOT_RECRUITING